A Two Part Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers and the Effects of Bendavia(TM) and Unfractionated Heparin When Administered Concurrently

Trial Profile

A Two Part Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers and the Effects of Bendavia(TM) and Unfractionated Heparin When Administered Concurrently

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Elamipretide (Primary) ; Heparin
  • Indications Blood coagulation disorders; Deep vein thrombosis; Diabetes mellitus; Eye disorders; Kidney disorders; Neurodegenerative disorders; Reperfusion injury
  • Focus Pharmacodynamics
  • Sponsors Stealth Peptides
  • Most Recent Events

    • 18 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top